Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
cbdMD ( (YCBD) ) has provided an announcement.
cbdMD, Inc., a U.S.-based CBD wellness company, disclosed that it has entered into a Third Amendment to its lease, effective May 20, 2026, signifying a modification to a material definitive agreement governing its facilities. The amendment, referenced in the company’s filing under the Securities Exchange Act of 1934 and executed by CEO and CFO T. Ronan Kennedy, highlights an adjustment to cbdMD’s operational footprint that may influence its long-term occupancy costs and infrastructure planning.
The company’s report, dated May 20, 2026, formalizes this lease amendment as part of its regulatory disclosure obligations, underscoring the material nature of the revised terms. While specific financial details were not disclosed in the release, the move signals ongoing management of real estate commitments that could affect cbdMD’s cost structure and flexibility in scaling its operations.
The most recent analyst rating on (YCBD) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on cbdMD stock, see the YCBD Stock Forecast page.
Spark’s Take on YCBD Stock
According to Spark, TipRanks’ AI Analyst, YCBD is a Neutral.
The score is held down primarily by weak financial performance—persistent losses, ongoing cash burn, and balance-sheet volatility. Earnings call commentary provides some offset via improving revenue trends and expectations for better contribution from the Bluebird acquisition and reduced cash burn, while technicals and valuation remain neutral-to-unfavorable.
To see Spark’s full report on YCBD stock, click here.
More about cbdMD
cbdMD, Inc. operates in the wellness and consumer products sector, focusing on cannabidiol (CBD)-based products for health and lifestyle markets. The company develops and sells CBD formulations aimed at retail consumers, positioning itself within the growing cannabinoid wellness industry in the United States.
Average Trading Volume: 1,513,427
Technical Sentiment Signal: Sell
Current Market Cap: $8.08M
For detailed information about YCBD stock, go to TipRanks’ Stock Analysis page.